Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2729 (LINC02729)
- Target
- LINC02729
- Molecular classification
- Long non-coding RNA, long intergenic non-coding RNA (lincRNA)
01
Overview
Long intergenic non-protein coding RNA 2729 (LINC02729) is a member of the long intergenic non-coding RNA (lincRNA) family, which refers to RNA molecules longer than 200 nucleotides that do not code for proteins and are transcribed from regions of the genome that do not overlap with protein-coding genes[3][1][7]. LINC02729, like other lincRNAs, is thought to play diverse roles in regulating gene expression, including chromatin modification, transcriptional control, RNA stabilization, and possibly enhancer-like regulatory activities[3][7]. LincRNAs often display tissue-specific functions and may act through multiple mechanisms to fine-tune the expression of neighboring genes[3]. While some lincRNAs are implicated as molecular markers in cancer or other diseases, there is currently no direct evidence that LINC02729 itself is used as a therapeutic target or that it interacts with specific drugs[1][2]. Its involvement in disease, biomarker status, mechanism of drug action, and safety concerns remain to be established.
- Other names
- LINC02729long intergenic non-protein coding RNA 2729
02
Biological functions
Chromatin remodelinggenome architecture regulationRNA stabilizationtranscription regulationenhancer-associated activitygene expression fine-tuning
03
Disease associations
Cancer (potential association in endometrial carcinoma molecular profiling)Other (general regulatory roles in disease may be possible but not established for this specific lincRNA)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 2729 (LINC02729).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2729 (LINC02729).